Kush Parmar
Chairman of the Board of Directors @Entrada Therapeutics
Boston, MA, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Sep 2016 — Present
Chairman of the Board of Directors @Entrada Therapeutics
View department →
Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics.
EDUCATION
2004 — 2008
Harvard University
Ph.D., Biomedical Sciences
2010 — 2010
Harvard Business School
Finance
2002 — 2010
Massachusetts Institute of Technology
M.D., HST Program
1998 — 2002
Princeton University
A.B., Molecular Biology, Medieval Studies
2002 — 2010
Harvard Medical School
MD
SKILLS
Technology TransferDrug DiscoveryEntrepreneurshipStart-UpsVenture CapitalStrategyBiotechnologyCorporate DevelopmentBusiness DevelopmentClinical DevelopmentCancerPrivate EquityLife SciencesCellOncologyLifesciencesCommercializationPharmaceutical Industry
ABOUT KUSH PARMAR
Managing Partner at 5AM Ventures
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.